Search Results

210 Results were found

Clinical course and management of paclitaxel extravasation

A Du Bois, M Fehr, H Bochtler, O Koechli

Pages: 973-974 Published on: 01 September 1996

Potential drug interaction between paclitaxel and clopidogrel

Yasutaka Shinoda, Michio Kimura, Eiseki Usami, Hiroki Asano, Tomoaki Yoshimura

Pages: 141-145 Published on: 01 July 2016

Antagonism of paclitaxel cytotoxicity by X-rays

J Liebmann, L Herscher, J Fisher, D Teague, J Cook

Pages: 991-996 Published on: 01 May 1996

Safety of nanoparticle albumin‑bound paclitaxel administered to breast cancer patients with clinical contraindications to paclitaxel or docetaxel: Four case reports

Kosei Kimura, Satoru Tanaka, Mitsuhiko Iwamoto, Hiroya Fujioka, Yuko Takahashi, Nayuko Sato, Risa Terasawa, Tomo Tominaga, Ayana Ikari, Kazuhisa Uchiyama

Pages: 881-884 Published on: 01 October 2013

Paclitaxel-coated balloons for the treatment of patients with in-stent restenosis: A meta-analysis of angiographic and clinical data

Jun Li, Wan‑Li Liu, Xin Yi, Gao‑Ke Feng, Zhao Lu, Xue‑Jun Jiang, Xiao‑Yan Li

Pages: 2285-2292 Published on: 01 June 2015

A multi-center, late phase II clinical trial of Genexol® (paclitaxel) and cisplatin for patients with advanced gastric cancer

Sook Ryun Park, Do-Youn Oh, Dong-Wan Kim, Tae-You Kim, Dae Seog Heo, Yung-Jue Bang, Noe Kyeong Kim, Won Ki Kang, Heung-Tae Kim, Seock-Ah Im, Jae-Hong Suh, Hark-Kyun Kim, Hoon-Kyo Kim

Pages: 1059-1064 Published on: 01 November 2004
Open Access

Role of hsa‑miR‑105 during the pathogenesis of paclitaxel resistance and its clinical implication in ovarian cancer

Mao Li, Shun Zhang, Yuan Ma, Yang Yang, Ruifang An

Pages: 1-13 Published on: 01 May 2021

Gemcitabine in combination with paclitaxel for advanced soft‑tissue sarcomas

Amir Sonnenblick, Feras Eleyan, Tamar Peretz, Inna Ospovat, Ofer Merimsky, Tamar Sella, Nili Peylan‑Ramu, Daniela Katz

Pages: 829-832 Published on: 01 July 2015
Open Access

Low-dose paclitaxel modulates tumour fibrosis in gastric cancer

Tomoya Tsukada, Sachio Fushida, Shinichi Harada, Shiroh Terai, Yasumichi Yagi, Jun Kinoshita, Katsunobu Oyama, Hidehiro Tajima, Itasu Ninomiya, Takashi Fujimura, Tetsuo Ohta

Pages: 1167-1174 Published on: 01 April 2013

Binding affinities of paclitaxel and docetaxel for generic and nanoparticle albumin‑bound paclitaxel‑derived albumin from human serum

Takamichi Sato, Manami Okazaki, Junko Sano, Chihiro Kato, Kazuhisa Shimizu, Masayuki Kitagawa

Pages: 1-1 Published on: 01 April 2021
Open Access

A phase II clinical trial of palonosetron for the management of delayed vomiting in gynecological cancer patients receiving paclitaxel/carboplatin therapy

Eriko Takatori, Tadahiro Shoji, Yuki Miura, Miyuki Nagao, Anna Takada, Takayuki Nagasawa, Hideo Omi, Masahiro Kagabu, Tatsuya Honda, Toru Sugiyama

Pages: 281-286 Published on: 01 March 2015

Clinical experience with nanoparticle albumin-bound paclitaxel, a novel taxane anticancer agent, and management of adverse events in females with breast cancer

Seiki Takashima, Sachiko Kiyoto, Mina Takahashi, Fumikata Hara, Kenjiro Aogi, Shozo Ohsumi, Ryoko Mukai, Yoriko Fujita

Pages: 1822-1826 Published on: 01 April 2015
Open Access

Clinical outcome of patients with inoperable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus Nab‑paclitaxel as a first‑line therapy: A retrospective analysis

Hiroyuki Sakaguchi, Azusa Tanimoto, Shigeki Sato, Naohiro Yanagimura, Chiaki Suzuki, Yohei Takumi, Akihiro Nishiyama, Kaname Yamashita, Shinji Takeuchi, Koshiro Ohtsubo, Seiji Yano

Pages: 1-5 Published on: 01 September 2021
Open Access

Paclitaxel plus nedaplatin vs. paclitaxel plus carboplatin in women with epithelial ovarian cancer: A multi-center, randomized, open-label, phase III trial

Li Li, Qingqing Zhuang, Zeyi Cao, Rutie Yin, Yaping Zhu, Lirong Zhu, Xing Xie, Youzhong Zhang, Qiang Wu, Jianhua Zheng, Qi Zhou, Xiaoping Li, Lingying Wu, Youji Feng, Changyu Wang

Pages: 3646-3652 Published on: 01 March 2018
Open Access

Efficacy and safety of TE/TEC/intensive paclitaxel neoadjuvant chemotherapy for the treatment of breast cancer

Yang Liu, Zhaoguo Xu, Zhenyong Zhang, Guangfu Wen, Jiaxing Sun, Feng Han

Pages: 907-912 Published on: 01 January 2019

Paralytic ileus due to a novel anticancer drug, nab‑paclitaxel: A case report

Xiao‑Dong Jiao, Xiu Luo, Wen‑Xing Qin, Ling‑Yan Yuan, Yuan‑Sheng Zang

Pages: 824-826 Published on: 01 May 2016

Beclin1 inhibition enhances paclitaxel‑mediated cytotoxicity in breast cancer in vitro and in vivo

Cheng‑Lin Wu, Jian‑Fei Liu, Yan Liu, Yu‑Xiao Wang, Kai‑Fei Fu, Xiao‑Jie Yu, Qian Pu, Xiu‑Xiu Chen, Li‑Jun Zhou

Pages: 1866-1878 Published on: 01 April 2019
Open Access

Liposomal paclitaxel induces fewer hematopoietic and cardiovascular complications than bioequivalent doses of Taxol

Shih-Ting Huang, Yi‑Ping Wang, Yen-Hui Chen, Chin-Tarng Lin, Wen-Shan Li, Han-Chung Wu

Pages: 1105-1117 Published on: 01 September 2018

Downregulated Mucin 1 alleviates paclitaxel resistance in non‑small cell lung cancer cells

Hongyu Xu, Hui Gao, Hua Li, Dong Li, Weiwei Yuan, Ling Zhang, Peng Cheng, Xiaomei Su, Zhihui Li, Guangjie Wang, Tao Zhang

Pages: 2966-2972 Published on: 01 October 2020

HDAC6-selective inhibitors enhance anticancer effects of paclitaxel in ovarian cancer cells

Jung Yoo, Yu Hyun Jeon, Dong Hoon Lee, Go Woon Kim, Sang Wu Lee, So Yeon Kim, Jongsun Park, So Hee Kwon

Pages: 1-1 Published on: 01 March 2021

Response to nab-paclitaxel and nedaplatin in a heavily-metastatic thymic carcinoma: A case report

Ping Zhan, Haiyan Xie, Li‑Ke Yu

Pages: 1715-1718 Published on: 01 April 2015
Open Access

Gold nanoparticle‑mediated delivery of paclitaxel and nucleic acids for cancer therapy (Review)

Zhiguang Wang, Jianyu Dong, Qiaojiajie Zhao, Ying Ying, Lijie Zhang, Junrong Zou, Shuqi Zhao, Jiuju Wang, Yuan Zhao, Shanshan Jiang

Pages: 4475-4484 Published on: 01 December 2020

Interaction of gemcitabine with paclitaxel and cisplatin in human tumor cell lines.

C Theodossiou, J A Cook, J Fisher, D Teague, J E Liebmann, A Russo, J B Mitchell

Pages: 825-857 Published on: 01 April 1998

Synergistic effect and condition of pegylated interferon α with paclitaxel on glioblastoma

Myung Jin Son, Hyun Seok Song, Mi Hyun Kim, Ji Tae Kim, Chang-Mo Kang, Ji Won Jeon, Shi-Young Park, Yung-Jin Kim, Morris D. Groves, Kwan Park, Jong-Hyun Kim, Do-Hyun Nam

Pages: 1385-1392 Published on: 01 June 2006

Inhibition of synuclein-γ expression increases the sensitivity of breast cancer cells to paclitaxel treatment

Yue Zhou, Satoru Inaba, Jingwen Liu

Pages: 289-295 Published on: 01 July 2006

Low doses of paclitaxel potently induce apoptosis in human retinoblastoma Y79 cells by up-regulating E2F1

Rosa Drago-Ferrante, Andrea Santulli, Riccardo Di Fiore, Michela Giuliano, Giuseppe Calvaruso, Giovanni Tesoriere, Renza Vento

Pages: 677-687 Published on: 01 October 2008

Amifostine enhancement of the anti-cancer effects of paclitaxel in endometrial cancer is TP53-dependent

Wentao Luo, Fan Wu, Ruba Elmaoued, Brandon B. Beck, Edgar Fischer, Xiangbing Meng, Kimberly K. Leslie, Donghai Dai

Pages: 1187-1194 Published on: 01 November 2010

Musashi-2 is a novel regulator of paclitaxel sensitivity in ovarian cancer cells

Jeongsuk Lee, Sungkwan An, Yeong Min Choi, Junwoo Lee, Kyu Joong Ahn, Jae Ho Lee, Tae Jin Kim, In-Sook An, Seunghee Bae

Pages: 1945-1952 Published on: 01 November 2016

Paclitaxel for relapsed small‑cell lung cancer patients with idiopathic interstitial pneumonias

Atsuro Saijo, Masaki Hanibuchi, Hirokazu Ogino, Kenji Otsuka, Hisatsugu Goto, Hiroshi Nokihara, Yasuhiko Nishioka

Pages: 541-546 Published on: 01 May 2019

Albumin-bound paclitaxel for the treatment of refractory or relapsed small-cell lung cancer

Hironori Yoshida, Young Hak Kim, Hiroaki Ozasa, Hiroki Nagai, Yuichi Sakamori, Takashi Nakaoku, Yoshitaka Yagi, Takahiro Tsuji, Takashi Nomizo, Michiaki Mishima

Pages: 213-215 Published on: 01 July 2016

Conversion therapy for pancreatic cancer with peritoneal metastases using intravenous and intraperitoneal paclitaxel with S-1

Hiromitsu Kitayama, Yasushi Tsuji, Tomohiro Kondo, Junko Sugiyama, Michiaki Hirayama, Kazuyuki Yamamoto, You Kawarada, Yumiko Oyamada, Satoshi Hirano

Pages: 779-782 Published on: 01 December 2016

Phase I study of third-line palliative chemotherapy with low dose paclitaxel for pancreatic cancer

Hidehiro Tajima, Mitsuyoshi Okazaki, Takahisa Yamaguchi, Yoshinao Ohbatake, Koichi Okamoto, Shinichi Nakanuma, Shiro Terai, Seisho Sakai, Jun Kinoshita, Isamu Makino, Keishi Nakamura, Hironori Hayashi, Katsunobu Oyama, Masafumi Inokuchi, Tomoharu Miyashita, Hiroyuki Takamura, Itasu Ninomiya, Sachio Fushida, Tetsuo Ohta

Pages: 623-627 Published on: 01 April 2018

miRNA-34a enhances the sensitivity of gastric cancer cells to treatment with paclitaxel by targeting E2F5

Lina Li, Cuiling Wu, Yue Zhao

Pages: 4837-4842 Published on: 01 June 2017

EphA2 silencing in nasopharyngeal carcinoma leads to decreased proliferation, invasion and increased sensitization to paclitaxel

Pingqing Tan, Yong Liu, Changyun Yu, Zhongwu Su, Guo Li, Xiaojuan Zhou, Donghai Huang, Xin Zhang, Yuanzheng Qiu, Yongquan Tian

Pages: 429-434 Published on: 01 September 2012

Anti-tumor effects of bevacizumab in combination with paclitaxel on head and neck squamous cell carcinoma

Kyoko Fujita, Daisuke Sano, Machiko Kimura, Yukiko Yamashita, Mariko Kawakami, Yukari Ishiguro, Goshi Nishimura, Hideki Matsuda, Mamoru Tsukuda

Pages: 47-51 Published on: 01 July 2007

Possibility of paclitaxel as an alternative radiosensitizer to 5-fluorouracil for colon cancer

Junichiro Hiro, Yasuhiro Inoue, Yuji Toiyama, Shigeyuki Yoshiyama, Koji Tanaka, Yasuhiko Mohri, Chikao Miki, Masato Kusunoki

Pages: 1029-1034 Published on: 01 October 2010

Low-dose paclitaxel suppresses the induction of M2 macrophages in gastric cancer

Takahisa Yamaguchi, Sachio Fushida, Yasuhiko Yamamoto, Tomoya Tsukada, Jun Kinoshita, Katsunobu Oyama, Tomoharu Miyashita, Hidehiro Tajima, Itasu Ninomiya, Seiichi Munesue, Ai Harashima, Shinichi Harada, Hiroshi Yamamoto, Tetsuo Ohta

Pages: 3341-3350 Published on: 01 June 2017
Open Access

Dietary baker's yeast sensitizes Ehrlich mammary adenocarcinoma to paclitaxel in mice bearing tumor

Mamdooh Ghoneum, Nariman K. Badr El-Din, Ashraf Z. Mahmoud, Lucilene Tolentino, Deyu Pan, Tahia Ali Hassan

Pages: 3155-3166 Published on: 01 June 2019

Paclitaxel and carboplatin in pretreated advanced gastric cancer: A phase II study

G. P. Stathopoulos, S. K. Rigatos, G. Fountzilas, A. Polyzos, J. G. Stathopoulos

Pages: 89-92 Published on: 01 January 2002
Open Access

Inhibition of FOXO1‑mediated autophagy promotes paclitaxel‑induced apoptosis of MDA‑MB‑231 cells

Kaixiang Xu, Wanyun Zhu, Anyong Xu, Zhe Xiong, Di Zou, Heng Zhao, Deling Jiao, Yubo Qing, Muhammad Ameen Jamal, Hong-Jiang Wei, Hong-Ye Zhao

Pages: 1-11 Published on: 01 February 2022

Breast cancer cells evade paclitaxel-induced cell death by developing resistance to dasatinib

Yun‑Ji Jeong, Jong Soon Kang, Su In Lee, Dong Min So, Jieun Yun, Ji Young Baek, Sang Kyum Kim, Kiho Lee, Song‑Kyu Park

Pages: 2153-2158 Published on: 01 September 2016
Open Access

Long non‑coding RNA ENST00000500843 is downregulated and promotes chemoresistance to paclitaxel in lung adenocarcinoma

Xin Tian, Song Gao, Yang Liu, Ying Xuan, Rong Wu, Zhenyong Zhang

Pages: 3716-3722 Published on: 01 October 2019

Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel

Ning Chen, Hye Sook Chon, Yin Xiong, Douglas C. Marchion, Patricia L. Judson, Ardeshir Hakam, Jesus Gonzalez-Bosquet, Jennifer Permuth-Wey, Robert M. Wenham, Sachin M. Apte, Jin Q. Cheng, Thomas A. Sellers, Johnathan M. Lancaster

Pages: 376-383 Published on: 01 January 2014

Microarray expression profile of long non-coding RNAs in paclitaxel-resistant human lung adenocarcinoma cells

Xin Tian, Hongyan Zhang, Bijun Zhang, Jianzhu Zhao, Tingting Li, Yanyan Zhao

Pages: 293-300 Published on: 01 July 2017

Curcumin and paclitaxel induce cell death in breast cancer cell lines

Gloria M. Calaf, Richard Ponce-Cusi, Flavio Carrión

Pages: 2381-2388 Published on: 01 October 2018
Open Access

Autophagy inhibition and microRNA‑199a‑5p upregulation in paclitaxel‑resistant A549/T lung cancer cells

Tianjiao Zeng, Mingshi Xu, Wanli Zhang, Xiaofan Gu, Fangqing Zhao, Xuan Liu, Xiongwen Zhang

Pages: 1-12 Published on: 01 July 2021

Bcl-2 overexpression is associated with resistance to paclitaxel, but not gemcitabine, in multiple myeloma cells.

Y Gazitt, M L Rothenberg, S G Hilsenbeck, V Fey, C Thomas, W Montegomrey

Pages: 839-887 Published on: 01 October 1998
Open Access

CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway

Linlin Wang, Fang Zhang, Jian‑Ying Cui, Liang Chen, Yue‑Ting Chen, Bo‑Wen Liu

Pages: 2081-2090 Published on: 01 May 2018

WWOX promotes apoptosis and inhibits autophagy in paclitaxel‑treated ovarian carcinoma cells

Yan Zhao, Wen Wang, Wenying Pan, Yunhai Yu, Wenqian Huang, Jiangang Gao, Ying Zhang, Shiqian Zhang

Pages: 1-1 Published on: 01 February 2021

Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: The importance of scheduling

Cristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Ramon Colomer, Rafael De Llorens, Joan Brunet, Javier A. Menendez

Pages: 113-120 Published on: 01 January 2008

Resistance to first line platinum paclitaxel chemotherapy in serous epithelial ovarian cancer: The prediction value of ERCC1 and Tau expression

Karina Dahl Steffensen, Marta Smoter, Marianne Waldstrøm, Bartłomiej Grala, Lubomir Bodnar, Rafał Stec, Cezary Szczylik, Anders Jakobsen

Pages: 1736-1744 Published on: 01 May 2014

Phase I study of weekly palliative chemotherapy with low-dose third-line paclitaxel for biliary tract cancer

Hidehiro Tajima, Tetsuo Ohta, Hiroyuki Shinbashi, Atsushi Hirose, Mitsuyoshi Okazaki, Takahisa Yamaguchi, Yoshinao Ohbatake, Koichi Okamoto, Shinichi Nakanuma, Seisho Sakai, Jun Kinoshita, Isamu Makino, Keishi Nakamura, Hironori Hayashi, Katsunobu Oyama, Masafumi Inokuchi, Tomoharu Miyashita, Hiroyuki Takamura, Itasu Ninomiya, Sachio Fushida, Hiroyuki Nakamura

Pages: 753-757 Published on: 01 May 2017

Association of the ABCB1 3435C>T polymorphism and treatment outcomes in advanced gastric cancer patients treated with paclitaxel-based chemotherapy

Hyun Chang, Sun Young Rha, Hei-Cheul Jeung, Chong Kun Im, Sung Hoon Noh, Jin Ju Kim, Hyun Cheol Chung

Pages: 271-278 Published on: 01 January 2010

Potentiation of antitumor effects of IL-12 in combination with paclitaxel in murine melanoma model in vivo.

R Zagozdzon, J Golab, K Mucha, B Foroncewicz, M Jakobisiak

Pages: 645-653 Published on: 01 December 1999

Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer

Spyridon Sideris, Fouad Aoun, Marc Zanaty, Nieves Chanza Martinez, Sofia Latifyan, Ahmad Awada, Thierry Gil

Pages: 1063-1067 Published on: 01 June 2016

IN-VITRO CYTOTOXICITY IN OVARIAN-CANCER OF LOW-DOSE CONTINUOUS EXPOSURE TO MICROTUBULE INHIBITORS (PACLITAXEL TAXOTERE) COMBINED WITH CISPLATIN

Y KIYOZUKA, H NISHIMURA, A NAKASHIMA, K IMAMURA, S OTA, M YAKUSHIJI, S IMAI, M MORIMATSU

Pages: 517-523 Published on: 01 July 1995

A phase II trial with gemcitabine and paclitaxel for the treatment of refractory and relapsed multiple myeloma patients

Yair Gazitt, Paul Shaughnessy, Mace L. Rothenberg

Pages: 877-884 Published on: 01 October 2006
Open Access

Evaluation of drug release from paclitaxel + hirudin‑eluting balloons and the resulting vascular reactivity in healthy pigs

Xian Wang, Hongmei Li, Xiaoting Sun, Xiaohang Wang, Gangyin Wang

Pages: 3425-3432 Published on: 01 October 2018

Safety and efficacy of a non‑polymeric paclitaxel‑eluting microporous stent in real‑world percutaneous coronary intervention

Shao‑Peng Wang, Rong‑Chong Huang, Hao Zhu, Bo Zhang, Zhen-Guo  Zheng, Da Yin, Jun-Jie Wang, Xu‑Chen Zhou

Pages: 811-815 Published on: 01 September 2013

Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death

Lihua Qiu, Wen Di, Qin Jiang, Erica Scheffler, Steven Derby, Jian Yang, Nicola Kouttab, Harold Wanebo, Bingfang Yan, Yinsheng Wan

Pages: 1441-1448 Published on: 01 November 2005

Dexamethasone inhibits paclitaxel-induced cytotoxic activity through retinoblastoma protein dephosphorylation in non-small cell lung cancer cells

Masato Morita, Hisashi Suyama, Tadashi Igishi, Yasushi Shigeoka, Masahiro Kodani, Kiyoshi Hashimoto, Kenichi Takeda, Takashi Sumikawa, Eiji Shimizu

Pages: 187-192 Published on: 01 January 2007

Safety and efficacy of carboplatin plus nab-paclitaxel for treating advanced non-small-cell lung cancer with interstitial lung disease

Hideyuki Niwa, Yoshiro Nakahara, Masanori Yokoba, Hisashi Mitsufuji, Jiichiro Sasaki, Noriyuki Masuda

Pages: 604-608 Published on: 01 October 2017
Open Access

Overexpression of microRNA‑24 increases the sensitivity to paclitaxel in drug‑resistant breast carcinoma cell lines via targeting ABCB9

Jian‑Ping Gong, Liu Yang, Jun‑Wei Tang, Peng Sun, Qing Hu, Jian‑Wei Qin, Xiao‑Ming Xu, Bei‑Cheng Sun, Jin‑Hai Tang

Pages: 3905-3911 Published on: 01 November 2016

Gene expression profiles with cDNA microarray reveal RhoGDI as a predictive marker for paclitaxel resistance in ovarian cancers

Tomoko Goto, Masashi Takano, Masaru Sakamoto, Ayako Kondo, Junko Hirata, Tsunekazu Kita, Hitoshi Tsuda, Yoshio Tenjin, Yoshihiro Kikuchi

Pages: 1265-1271 Published on: 01 May 2006

Paclitaxel and ceramide synergistically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cells

Lihua Qiu, Changlin Zhou, Yun Sun, Wen Di, Erica Scheffler, Sarah Healey, Harold Wanebo, Nicola Kouttab, Wenming Chu, Yinsheng Wan

Pages: 907-913 Published on: 01 October 2006

Combination treatment with paclitaxel and doxorubicin inhibits growth of human esophageal squamous cancer cells by inactivation of Akt

Hwan Hee Lee, Shuai Ye, Xiu Juan Li, Kwang Bok Lee, Man Hee Park, Soo Mi Kim

Pages: 183-188 Published on: 01 January 2014

Improved safety and efficacy of a lipid emulsion loaded with a paclitaxel-cholesterol complex for the treatment of breast tumors

Jun Ye, Yuling Liu, Xuejun Xia, Luhua Meng, Wujun Dong, Renyun Wang, Zhaodi Fu, Hongyan Liu, Rui Han

Pages: 399-409 Published on: 01 July 2016
Open Access

Proteasome inhibitors decrease paclitaxel‑induced cell death in nasopharyngeal carcinoma with the accumulation of CDK1/cyclin B1

Ling Hu, Xi Pan, Jinyue Hu, Hong Zeng, Xueting Liu, Manli Jiang, Binyuan Jiang

Pages: 1-11 Published on: 01 October 2021
Open Access

Targeting Mps1 in combination with paclitaxel inhibits osteosarcoma progression by modulating spindle assembly checkpoint and Akt/mTOR signaling

Lu Lu, Yuhai Wang, Jian Chen, Ye Li, Qingyang Liang, Feng Li, Chuanchuan Zhen, Kegong Xie

Pages: 1-11 Published on: 01 November 2021

Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer

Yoko Tabuchi, Junji Matsuoka, Mehmet Gunduz, Takako Imada, Ryoko Ono, Mitsuya Ito, Takayuki Motoki, Tomoki Yamatsuji, Yasuhiro Shirakawa, Munenori Takaoka, Minoru Haisa, Noriaki Tanaka, Junichi Kurebayashi, V. Craig Jordan, Yoshio Naomoto

Pages: 313-319 Published on: 01 February 2009

Prospective validation of patient fatigue questionnaire (FACIT‑F) for fatigue assessment in nab‑paclitaxel plus gemcitabine therapy

Ken‑Ichi Okada, Seiko Hirono, Manabu Kawai, Motoki Miyazawa, Atsushi Shimizu, Yuji Kitahata, Masaki Ueno, Shinya Hayami, Toshio Shimokawa, Hiroki Yamaue

Pages: 121-126 Published on: 01 January 2018

A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth

Douglas C. Marchion, Elona Bicaku, Yin Xiong, Nadim Bou Zgheib, Entidhar Al Sawah, Xiaomang Ba Stickles, Patricia L. Judson, Alex S. Lopez, Christopher L. Cubitt, Jesus Gonzalez-Bosquet, Robert M. Wenham, Sachin M. Apte, Anders Berglund, Johnathan M. Lancaster

Pages: 2011-2018 Published on: 01 May 2013

A phase I study of preoperative (neoadjuvant) chemotherapy with gemcitabine plus nab‑paclitaxel for resectable pancreatic cancer

Hidehiro Tajima, Isamu Makino, Ryosuke Gabata, Mitsuyoshi Okazaki, Yoshinao Ohbatake, Hiroyuki Shimbashi, Shinich Nakanuma, Hiroto Saitoh, Mari Shimada, Takahisa Yamaguchi, Koichi Okamoto, Hideki Moriyama, Jun Kinoshita, Keishi Nakamura, Tomoharu Miyashita, Itasu Ninomiya, Sachio Fushida, Hiroko Ikeda, Tetsuo Ohta

Pages: 1-1 Published on: 01 February 2021

Phase II study of neoadjuvant anthracycline combined with nanoparticle albumin‑bound paclitaxel for human epidermal growth factor receptor 2‑negative breast cancer

Emi Ishigami, Masahiro Sakakibara, Junta Sakakibara, Toshiaki Iwase, Shoko Hayama, Takahito Masuda, Ayako Nakagawa, Takeshi Nagashima, Takafumi Sangai, Hiroshi Fujimoto, Masayuki Otsuka

Pages: 1079-1082 Published on: 01 December 2017
Open Access

Ipatasertib exhibits anti‑tumorigenic effects and enhances sensitivity to paclitaxel in endometrial cancer <em>in vitro</em> and <em>in vivo</em>

Jillian O'Donnell, Ziyi Zhao, Lindsey Buckingham, Tianran Hao, Hongyan Suo, Xin Zhang, Yali Fan, Catherine John, Boer Deng, Xiaochang Shen, Wenchuan Sun, Angeles Alvarez Secord, Chunxiao Zhou, Victoria L. Bae-Jump

Pages: 1-14 Published on: 01 September 2023

Retrospective analysis of acute exacerbation of interstitial lung diseases with nanoparticle albumin-bound paclitaxel in patients with advanced lung cancer with preexisting interstitial lung disease

Yuto Yasuda, Takashi Nomizo, Hiroaki Ozasa, Tomoko Funazo, Takahiro Tsuji, Hironori Yoshida, Yuichi Sakamori, Hiroki Nagai, Tomohiro Handa, Takeshi Kubo, Young Hak Kim

Pages: 677-680 Published on: 01 October 2017

Nab‑paclitaxel plus gemcitabine as first‑line palliative chemotherapy in a patient with metastatic pancreatic cancer with Eastern Cooperative Oncology Group performance status of 2

Andrés J. Muñoz Martín, Pilar García Alfonso, Ana B. Rupérez, Miguel Martín Jiménez

Pages: 727-730 Published on: 01 July 2016

ErbB3 expression predicts sensitivity to elisidepsin treatment: in vitro synergism with cisplatin, paclitaxel and gemcitabine in lung, breast and colon cancer cell lines

Cristina Teixidó, Elisabet Arguelaguet, Berta Pons, Miguel Aracil, Jose Jimeno, Rosa Somoza, Roso Marés, Santiago Ramón y Cajal, Javier Hernández-Losa

Pages: 317-324 Published on: 01 July 2012
Open Access

Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancer

Kiyoko Umene, Megumi Yanokura, Kouji Banno, Haruko Irie, Masataka Adachi, Miho Iida, Kanako Nakamura, Yuya Nogami, Kenta Masuda, Yusuke Kobayashi, Eiichiro Tominaga, Daisuke Aoki

Pages: 1498-1506 Published on: 01 April 2015
Open Access

Regulatory T‑cell density and cytotoxic T lymphocyte density are associated with complete response to neoadjuvant paclitaxel and carboplatin chemoradiotherapy in gastric cancer

Di Huang, Yongjiang Yang, Shuai Zhang, Zhuobin Su, Tao Peng, Xiaoyuan Wang, Yifeng Zhao, Shuguang Li

Pages: 3813-3820 Published on: 01 November 2018

Thrombotic thrombocytopenic purpura following salvage chemotherapy with paclitaxel, ifosfamide and cisplatin in a patient with a refractory germ cell tumor: A case report and review of the literature

Arife Ulas, Kamile Silay, Sema Akinci, Muhammed Bulent Akinci, Mehmet Ali Sendur, Didem Sener Dede, Yunus Halil Polat, Bulent Yalcin

Pages: 2223-2226 Published on: 01 October 2015
Open Access

Apatinib combined with trastuzumab and albumin‑bound paclitaxel for treatment of HER2+ breast cancer with brain metastases resistant to anti‑HER2 TKIs: A case report

Jiayi Huang, Xiao Chen, Jinfeng Guo, Lin Song, Yanxi Mu, Han Zhao, Caiwen Du

Pages: 1-6 Published on: 01 February 2023

Curcumin improves the paclitaxel‑induced apoptosis of HPV‑positive human cervical cancer cells via the NF‑κB‑p53‑caspase‑3 pathway

Yu-Ping Dang, Xiao-Ying Yuan, Rong Tian, Dong-Guang Li, Wei Liu

Pages: 1470-1476 Published on: 01 April 2015

Antitumor effects of lapatinib (GW572016), a dual inhibitor of EGFR and HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinoma

Norio Kondo, Mamoru Tsukuda, Yukari Ishiguro, Machiko Kimura, Kyoko Fujita, Atsuko Sakakibara, Hideaki Takahashi, Gabor Toth, Hideki Matsuda

Pages: 957-963 Published on: 01 April 2010

Induced IGF-1R activation contributes to gefitinib resistance following combined treatment with paclitaxel, cisplatin and gefitinib in A549 lung cancer cells

Xiaojun Ge, Qingjuan Chen, Yang Ping Wu, Yuchen  Zhang, Hongwei Xia, Dandan  Yuan, Qi  Chen, Weibing  Leng, Liang  Chen, Qiulin  Tang, Xiaohui  Pang, Feng Bi

Pages: 1401-1408 Published on: 01 October 2014

Digitoxin and its synthetic analog MonoD have potent antiproliferative effects on lung cancer cells and potentiate the effects of hydroxyurea and paclitaxel

Juan Sebastian Yakisich, Neelam Azad, Rajkumar Venkatadri, Yogesh Kulkarni, Clayton Wright, Vivek Kaushik, George A. O'Doherty, Anand Krishnan V. Iyer

Pages: 878-886 Published on: 01 February 2016
Open Access

​Efficacy and safety of pyrotinib in combination with albumin‑bound paclitaxel for the treatment of HER2‑positive advanced breast cancer: A real‑world study

Lixian Yang, Lei Zheng, Fanting Kong, Xinli Tian, Shiyu Zhang, Pengpeng Pu

Pages: 1-9 Published on: 01 July 2023
Open Access

RBM15‑mediating MDR1 mRNA m<sup>6</sup>A methylation regulated by the TGF‑β signaling pathway in paclitaxel‑resistant ovarian cancer

Jia Yuan, Wencai Guan, Xin Li, Fanchen Wang, Huiqiang Liu, Guoxiong Xu

Pages: 1-15 Published on: 01 October 2023

Pathological complete response rate in hormone receptor-negative breast cancer treated with neoadjuvant FEC, followed by weekly paclitaxel administration: A retrospective study and review of the literature

Takayoshi Kiba, Nao Morii, Hirotoshi Takahashi, Shinji Ozaki, Misao Atsumi, Fumi Masumoto, Hiroyasu Yamashiro

Pages: 3064-3070 Published on: 01 May 2016
Open Access

Efficacy of nab‑paclitaxel vs. Gemcitabine in combination with S‑1 for advanced pancreatic cancer: A multicenter phase II randomized trial

Xi Guo, Wenhui Lou, Yaolin Xu, Rongyuan Zhuang, Lie Yao, Junwei Wu, Deliang Fu, Jun Zhang, Jing Liu, Yefei Rong, Dayong Jin, Wenchuan Wu, Xuefeng Xu, Yuan Ji, Lili Wu, Minzhi Lv, Xiuzhong Yao, Xiaowei Liu, Dansong Wang, Tiantao Kuang, Liang Liu, Wenquan Wang, Tianshu Liu, Yuhong Zhou

Pages: 1-11 Published on: 01 April 2024

Pre-clinical evaluation of new antineoplastic agents in NSCLC cell lines: evidence of histological subtype-dependent cytotoxicity.

M Loprevite, R E Favoni, A de Cupis, P Pirani, F Merlo, F Grossi, A Ardizzoni

Pages: 787-879 Published on: 01 October 1999

Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers

Philip P. Connell, Krishanthi Jayathilaka, Daniel J. Haraf, Ralph R. Weichselbaum, Everett E. Vokes, Mark W. Lingen

Pages: 1113-1119 Published on: 01 May 2006

Clinical research of individualized therapy in advanced esophageal cancer based on the ERCC1 C8092A genotype

Yi‑Wei Yao, Yi‑Fu He, Xing‑Hua Han, Chu‑Shu Ji, Bing Hu

Pages: 2539-2548 Published on: 01 August 2018
Open Access

PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective (Review)

Vera Loizzi, Girolamo Ranieri, Mariarita Laforgia, Cosmo   Damiano Gadaleta, Giulio Gargano, Anila Kardhashi, Maria De Liso, Emanuele Naglieri, Vittoria Del Vecchio, Ettore Cicinelli, Gennaro Cormio

Pages: 1-1 Published on: 01 October 2020

   Page 1 of 21